Unknown

Dataset Information

0

Rosiglitazone promotes PPAR?-dependent and -independent alterations in gene expression in mouse islets.


ABSTRACT: The glitazone class of insulin-sensitizing agents act, in part, by the activation of peroxisome proliferator-activated receptor (PPAR)-? in adipocytes. However, it is unclear whether the expression of PPAR? in the islets is essential for their potential ?-cell-sparing properties. To investigate the in vivo effects of rosiglitazone on ?-cell biology, we used an inducible, pancreatic and duodenal homeobox-1 enhancer element-driven, Cre recombinase to knockout PPAR? expression specifically in adult ?-cells (PPARgKO). Subjecting the PPARgKO mice to a chow diet led to virtually undetectable changes in glucose or insulin sensitivity, which was paralleled by minimal changes in islet gene expression. Similarly, challenging the mutant mice with a high-fat diet and treatment with rosiglitazone did not alter insulin sensitivity, glucose-stimulated insulin secretion, islet size, or proliferation in the knockout mice despite PPAR?-dependent and -independent changes in islet gene expression. These data suggest that PPAR? expression in the ?-cells is unlikely to be directly essential for normal ?-cell function or the insulin-sensitizing actions of rosiglitazone.

SUBMITTER: Welters HJ 

PROVIDER: S-EPMC3512010 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets.

Welters Hannah J HJ   El Ouaamari Abdelfattah A   Kawamori Dan D   Meyer John J   Hu Jiang J   Smith David M DM   Kulkarni Rohit N RN  

Endocrinology 20120717 10


The glitazone class of insulin-sensitizing agents act, in part, by the activation of peroxisome proliferator-activated receptor (PPAR)-γ in adipocytes. However, it is unclear whether the expression of PPARγ in the islets is essential for their potential β-cell-sparing properties. To investigate the in vivo effects of rosiglitazone on β-cell biology, we used an inducible, pancreatic and duodenal homeobox-1 enhancer element-driven, Cre recombinase to knockout PPARγ expression specifically in adult  ...[more]

Similar Datasets

| S-EPMC7240111 | biostudies-literature
| S-EPMC3062249 | biostudies-literature
| S-EPMC3642978 | biostudies-literature
| S-EPMC4878265 | biostudies-literature
| S-EPMC3902427 | biostudies-literature
| S-EPMC6600265 | biostudies-literature
| S-EPMC3268985 | biostudies-literature
| S-EPMC2865297 | biostudies-literature
| S-EPMC8683476 | biostudies-literature
| S-EPMC4243497 | biostudies-literature